Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

Gemcitabine resistance is a common problem of pancreatic cancer chemotherapy, and how to reverse it plays an important role in the treatment of pancreatic cancer. This study investigated the effect of emodin on the gemcitabine-resistant pancreatic cancer cell line SW1990/Gem, and explored the potent...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: LIU, DIAN-LEI, BU, HEQI, LI, HONG, CHEN, HUI, GUO, HONG-CHUN, WANG, ZHAO-HONG, TONG, HONG-FEI, NI, ZHONG-LIN, LIU, HAI-BIN, LIN, SHENG-ZHANG
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2011
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584653/
https://ncbi.nlm.nih.gov/pubmed/22159556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2011.1285
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires